Geneva, Switzerland

Isabelle Huber


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Isabelle Huber

Introduction

Isabelle Huber is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as protein kinase inhibitors. With a total of three patents to her name, Huber's work is recognized for its potential impact on treating various medical conditions.

Latest Patents

Among her latest patents, Huber has developed azepanes and their ring homologues that exhibit protein kinase inhibiting properties. These compounds, defined by specific formulas, are noted for their effectiveness as medicaments, especially in the treatment of inflammatory skin disorders and alopecia. The detailed specifications of these compounds highlight their active components, which are crucial for their medicinal applications.

Career Highlights

Isabelle Huber has established herself as a key figure in her field through her innovative research and patent contributions. Her work at Hoffmann-La Roche Inc. has allowed her to collaborate with leading experts and contribute to groundbreaking advancements in pharmaceutical science.

Collaborations

Throughout her career, Huber has worked alongside notable colleagues such as Pierre Barbier and Fernand Schneider. These collaborations have further enriched her research and expanded the scope of her innovative projects.

Conclusion

Isabelle Huber's contributions to the field of medicinal chemistry and her innovative patents underscore her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…